SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: SG who wrote (11616)10/22/2012 2:07:41 PM
From: pincus3 Recommendations  Read Replies (1) | Respond to of 13111
 
It appears to me that the ill-advised IPO has cratered the stock's worth. And really, it's past time to devise exist strategies.



To: SG who wrote (11616)10/23/2012 9:28:49 AM
From: Mammon  Read Replies (1) | Respond to of 13111
 
SG,
I think selling and taking a tax loss wouldn't be a great idea, especially if you don't have a lot of gains to balance it with. They've got to come up with some way to finance the phase III, and whatever that is might raise the stock price. I could not agree more that it would feel satisfying to hit the sell key after last week's debacle, but I think that going for a run when you feel that way would be a more productive use of your time.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News